Exploring the Latest Moves in Arnold Van Den Berg (Trades, Portfolio)'s Investment Strategy Warning! GuruFocus has detected 6 Warning Signs with COOP. Arnold Van Den Berg (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into his investment moves during this period. Since founding Century Management in 1974, Arnold Van Den Berg (Trades, Portfolio) has consistently outperformed major indices. As a dedicated value investor and a disciple of Benjamin Graham, Van Den Berg employs a strategy focused on determining a company's intrinsic value and investing at a significant discount, typically 40% to 65% below this value, ensuring a margin of safety. His portfolio usually comprises 35-40 U.S.-based companies, reflecting his commitment to value investment principles. Summary of New Buy Arnold Van Den Berg (Trades, Portfolio) added a total of 5 stocks, among them: The most significant addition was Intel Corp (NASDAQ:INTC), with 240,204 shares, accounting for 1.39% of the portfolio and a total value of $4.82 million. The second largest addition to the portfolio was Dell Technologies Inc (NYSE:DELL), consisting of 34,805 shares, representing approximately 1.16% of the portfolio, with a total value of $4.01 million. The third largest addition was Alkami Technology Inc (NASDAQ:ALKT), with 6,088 shares, accounting for 0.06% of the portfolio and a total value of $223,310. Key Position Increases Arnold Van Den Berg (Trades, Portfolio) also increased stakes in a total of 28 stocks, among them: The most notable increase was Thermo Fisher Scientific Inc (NYSE:TMO), with an additional 4,907 shares, bringing the total to 8,588 shares. This adjustment represents a significant 133.31% increase in share count, a 0.74% impact on the current portfolio, with a total value of $4.47 million. The second largest increase was The Cigna Group (NYSE:CI), with an additional 8,532 shares, bringing the total to 13,131. This adjustment represents a significant 185.52% increase in share count, with a total value of $3.63 million. Summary of Sold Out Arnold Van Den Berg (Trades, Portfolio) completely exited 3 holdings in the fourth quarter of 2024, as detailed below: DMC Global Inc (NASDAQ:BOOM): Arnold Van Den Berg (Trades, Portfolio) sold all 61,439 shares, resulting in a -0.23% impact on the portfolio. Schwab 1-5 Year Corporate Bond ETF (SCHJ): Arnold Van Den Berg (Trades, Portfolio) liquidated all 17,496 shares, causing a -0.13% impact on the portfolio. Key Position Reduces Arnold Van Den Berg (Trades, Portfolio) also reduced positions in 50 stocks. The most significant changes include: Story Continues Reduced Meta Platforms Inc (NASDAQ:META) by 3,026 shares, resulting in a -25.78% decrease in shares and a -0.5% impact on the portfolio. The stock traded at an average price of $587.14 during the quarter and has returned 27.65% over the past 3 months and 25.73% year-to-date. Reduced Seabridge Gold Inc (NYSE:SA) by 76,506 shares, resulting in a -10.91% reduction in shares and a -0.37% impact on the portfolio. The stock traded at an average price of $15.38 during the quarter and has returned -20.80% over the past 3 months and 1.14% year-to-date. Portfolio Overview At the fourth quarter of 2024, Arnold Van Den Berg (Trades, Portfolio)'s portfolio included 109 stocks. The top holdings included 5.77% in Berkshire Hathaway Inc (NYSE:BRK.B), 5.19% in Exxon Mobil Corp (NYSE:XOM), 5.14% in Sprott Physical Gold Trust (PHYS), 4.24% in Coherent Corp (NYSE:COHR), and 4% in Alphabet Inc (NASDAQ:GOOG). The holdings are mainly concentrated in 9 of the 11 industries: Energy, Financial Services, Technology, Communication Services, Healthcare, Consumer Cyclical, Industrials, Basic Materials, and Real Estate. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. View Comments
Intel Corp: A Significant Addition to Arnold Van Den Berg's Portfolio
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...